Intriguing Talks Mark ACTRI Translational Science Symposium

Former FDA commissioner Robert Califf, MD, and four researchers supported by UC San Diego Altman Clinical and Translational Research Institute (ACTRI) delivered inspiring presentations during the 2018 ACTRI Translational Science Symposium on April 5. The theme of the program was “Emerging Issues and Solutions in Infectious Disease.” More than 100 researchers and research staff from UC San Diego and partner institutions attended the symposium, which took place at the ACTRI Building. Scientists presenting their work included Aaron Carlin, MD, PhD; Jeannie Huang, MD, MPH; Frank Talke, PhD; and Gabriel Wagner, MD. The event opened with a welcome by ACTRI director Gary S. Firestein, MD, and the presentation of the 2018 Daniel T. O’Connor Memorial Award to Kevin King, MD, PhD, and concluded with the keynote talk by Dr. Califf, who was introduced by Anthony Magit, MD. ACTRI executive committee members Colin Depp, PhD, and Paul Mills, PhD, co-led the symposium. The presentation titles are below.

Speakers

Speakers and leaders during the ACTRI Translational Science Symposium are (from left): Jeannie Huang, MD, MPH; Paul Mills, PhD; Colin Depp, PhD; Frank Talke, PhD; Gabriel Wagner, MD; Aaron Carlin, MD, PhD; Robert Califf, MD; and Gary S. Firestein, MD.

Awardee

Joining hands (from left) are: ACTRI leader Paul Mills, PhD; Kellie Evans-O’Connor; and Kevin King, MD, PhD, recipient of the 2018 Daniel T. O’Connor Memorial Award. Ms. Evans-O’Connor, the widow of Dr. O’Connor, established the award to provide an additional $5,000 of support each year to the top-ranked ACTRI pilot project. She and Dr. Mills presented the award to Dr. King during the symposium. Read more about Dr. King and his project, “Clinical Pilot of Single Cell Analysis during Human Cardiac Ischemia and Infarction.”

KEYNOTE SPEAKER

Robert Califf, MD
Former FDA Commissioner
Former Vice Chancellor of Clinical and Translational Research, Duke University

Talk Title:
Role of “Real World Evidence” and Big Data in Development and Assessment of Therapies

ACTRI RESEARCH HIGHLIGHTS

Aaron Carlin, MD, PhD
Department of Medicine
UC San Diego

Talk Title:
Deconvolution of Anti-host and Anti-viral Genomic Responses in Zika Virus-infected and Bystander Human Macrophages

Jeannie Huang, MD, MPH 
Department of Pediatrics
UC San Diego

Talk Title:
Improving Pediatric Hepatitis B Screening in High-Risk San Diego Communities


Frank Talke, PhD
Jacobs School of Engineering
UC San Diego

AND

Thomas Savides, MD
Chief Experience Officer, UC San Diego Health
Division of Gastroenterology
UC San Diego

Talk Title:
Disposable, 3-D Printable Endoscope: Development of a Safer Endoscope to Prevent Infection Transmission Between Patients

Gabriel Wagner, MD 
Department of Medicine, Division of Infectious Diseases
UC San Diego

Talk Title:
HIV-1 Dual Infection and Neurocognitive Impairment 


About UC San Diego Altman Clinical and Translational Research Institute:

UC San Diego Altman Clinical and Translational Research Institute (ACTRI) is part of a national Clinical and Translational Science Award consortium, led by the National Institutes of Health National Center for Advancing Translational Science. Established in 2010, ACTRI provides infrastructure and support for basic, translational and clinical research throughout the San Diego region to bring discoveries from the laboratory to the bedside, and facilitates training and education of the next generation of researchers. ACTRI carries out its activities in collaboration with institutional and corporate partners and currently has more than 1,500 members.

actri.ucsd.edu